Evaluate the effect of lifestyle modification through the adoption of a DASH diet, with and without physical activity guidance, on blood pressure and insulin sensitivity in elderly patients with type 2 diabetes and hypertension.
Data regarding the effects of physical activity and DASH-type diet on blood pressure control in patients with type 2 diabetes and hypertension are scarce in the literature, whether evaluating these isolated interventions or together. In addition, most studies do not measure BP using ABPM, which has a special importance in the assessment of pressure homeostasis in DM or are short-term studies. Were only two studies have been identified in the literature that evaluated the effect of the DASH diet on patients with type 2 DM; however, in both trials, being elderly was not an inclusion criterion. The first was an Iranian study that demonstrated in 31 non-hypertensive patients a significant reduction in BP after 8 weeks of following a DASH diet. In the second ECR, we demonstrated that in 20 hypertensive type 2 DM patients, all using antihypertensive drugs and with uncontrolled BP, a DASH-type diet for 4 weeks associated with physical activity reduced the systolic BP assessed by ABPM by 12.5 mmHg. However, the adopted design did not allow to separate the effect of diet from the effect of physical activity. On the other hand, the effect of a single session of walking followed by a 24-hour ABPM assessment showed a reduction in BP in hypertensive elderly and non-hypertensive patients, also without DM. So far it is not defined in patients with type 2 DM and hypertension, especially the elderly, whether the DASH diet alone is as beneficial for BP as its association with physical activity, particularly, considering the difficulties of performing exercises in this group of patients. This is valuable information, as it would reinforce the role of diet therapy intervention even if in isolation in this age group. Furthermore, the role of the DASH diet with or without physical activity remains unknown on insulin sensitivity.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
37
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Change from Baseline Blood Pressure at 4 months
24 hours ambulatory blood pressure monitoring (ABPM)
Time frame: Baseline and 4 months
Change from Baseline Insulin Sensitivity at 4 months
HOMA index (using serum fasting insulin and glucose)
Time frame: Baseline and 4 months
Change from Baseline Glucose Profile at 4 months
Fasting glucose and A1C
Time frame: Baseline and 4 months
Change from Baseline Weight at 4 months anthropometric variables
weight in kilograms
Time frame: Baseline and 4 months
Change from Baseline BMI at 4 months
BMI in kg/m2
Time frame: Baseline and 4 months
Change from Baseline Skeletal muscle mass at 4 months
Skeletal muscle mass in Kilograms
Time frame: Baseline and 4 months
Change from Baseline Body fat mass at 4 months
Body fat mass in kilograms
Time frame: Baseline and 4 months
Change from Baseline Percent body Fat at 4 months
Percent body Fat (%)
Time frame: Baseline and 4 months
Change from Baseline Total cholesterol at 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Total cholesterol in mg/dl
Time frame: Baseline and 4 months
Change from Baseline LDL cholesterol at 4 months
LDL cholesterol in mg/dl
Time frame: Baseline and 4 months
Change from Baseline Triglycerides at 4 months
Triglycerides in mg/dl
Time frame: Baseline and 4 months
Change from Baseline HDL cholesterol at 4 months
HDL cholesterol in mg/dl
Time frame: Baseline and 4 months